Medbelle, the London and Berlin-based startup offering what it calls an “end-to-end platform” for medical procedures, has raised $7 million in Series A funding. The round was led by Signals Venture Capital — the VC fund of major German health insurer Signal Iduna — with participation from Talis Capital, Mutschler Ventures, IBB and Cavalry Ventures.
Founded in 2016 by Leander de Laporte and Daniel Kolb after the pair turned down jobs at Rocket Internet, Medbelle has set out to digitise the patient journey and provide medical treatments in a more modern, convenient and consumer-centric way. Likened to a “digital hospital,” the company lets patients book a number of medical procedures through its web and app-based platform.
These currently span cosmetics, bariatrics and ophthalmology, with plans underway to expand into orthopaedics and fertility treatment. At the moment, Medbelle only services private patients, but says it wants to work with the U.K.’s National Health Service and private and public health insurance providers to broaden its reach.
“Our vision is to create a world in which all patients can navigate their treatment journey digitally and receive personal care at the click of a button,” Medbelle co-founder Leander de Laporte tells me. “There is a massive